Literature DB >> 16292665

Human low-density lipoprotein receptor gene and its regulation.

Wei-Jia Kong1, Jingwen Liu, Jian-Dong Jiang.   

Abstract

The low-density lipoprotein (LDL) receptor is a transmembrane glycoprotein that mediates the binding and endocytosis of lipoproteins containing apolipoprotein B and E, especially the cholesterol-rich LDL. Mutations in the LDL receptor gene can produce dysfunctional LDL receptors and cause familial hypercholesterolemia. The expression of the LDL receptor gene is under an intriguing regulation by sterol and nonsterol mediators either at the transcriptional level or at the posttranscriptional level, both of which are linked to cell signaling pathways. Upregulation of liver LDL receptor expression is effective in treating hypercholesterolemia. In this review, we focus on the latest progress on the mechanisms and regulation of the LDL receptor gene expression.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16292665     DOI: 10.1007/s00109-005-0717-6

Source DB:  PubMed          Journal:  J Mol Med (Berl)        ISSN: 0946-2716            Impact factor:   4.599


  82 in total

Review 1.  Mitogen-activated protein kinase pathways.

Authors:  M J Robinson; M H Cobb
Journal:  Curr Opin Cell Biol       Date:  1997-04       Impact factor: 8.382

2.  Interleukin-6 stimulates LDL receptor gene expression via activation of sterol-responsive and Sp1 binding elements.

Authors:  H Gierens; M Nauck; M Roth; R Schinker; C Schürmann; H Scharnagl; G Neuhaus; H Wieland; W März
Journal:  Arterioscler Thromb Vasc Biol       Date:  2000-07       Impact factor: 8.311

3.  Identification of a novel sterol-independent regulatory element in the human low density lipoprotein receptor promoter.

Authors:  J Liu; T E Ahlborn; M R Briggs; F B Kraemer
Journal:  J Biol Chem       Date:  2000-02-18       Impact factor: 5.157

4.  Doubling expression of the low density lipoprotein receptor by truncation of the 3'-untranslated region sequence ameliorates type iii hyperlipoproteinemia in mice expressing the human apoe2 isoform.

Authors:  C Knouff; S Malloy; J Wilder; M K Altenburg; N Maeda
Journal:  J Biol Chem       Date:  2000-11-13       Impact factor: 5.157

5.  Effects of triiodothyronine and amiodarone on the promoter of the human LDL receptor gene.

Authors:  O Bakker; F Hudig; S Meijssen; W M Wiersinga
Journal:  Biochem Biophys Res Commun       Date:  1998-08-19       Impact factor: 3.575

Review 6.  Role of mitogen-activated protein kinases and protein kinase C in regulating low-density lipoprotein receptor expression.

Authors:  Kamal D Mehta
Journal:  Gene Expr       Date:  2002

7.  Posttranslational processing of the LDL receptor and its genetic disruption in familial hypercholesterolemia.

Authors:  H Tolleshaug; J L Goldstein; W J Schneider; M S Brown
Journal:  Cell       Date:  1982-10       Impact factor: 41.582

8.  The estradiol-stimulated lipoprotein receptor of rat liver. A binding site that membrane mediates the uptake of rat lipoproteins containing apoproteins B and E.

Authors:  E E Windler; P T Kovanen; Y S Chao; M S Brown; R J Havel; J L Goldstein
Journal:  J Biol Chem       Date:  1980-11-10       Impact factor: 5.157

9.  SREBP-1, a membrane-bound transcription factor released by sterol-regulated proteolysis.

Authors:  X Wang; R Sato; M S Brown; X Hua; J L Goldstein
Journal:  Cell       Date:  1994-04-08       Impact factor: 41.582

10.  Second-site cleavage in sterol regulatory element-binding protein occurs at transmembrane junction as determined by cysteine panning.

Authors:  E A Duncan; U P Davé; J Sakai; J L Goldstein; M S Brown
Journal:  J Biol Chem       Date:  1998-07-10       Impact factor: 5.157

View more
  12 in total

1.  Regulation of Kruppel-like factor 4, 9, and 13 genes and the steroidogenic genes LDLR, StAR, and CYP11A in ovarian granulosa cells.

Authors:  Sekar Natesampillai; Jason Kerkvliet; Peter C K Leung; Johannes D Veldhuis
Journal:  Am J Physiol Endocrinol Metab       Date:  2007-12-04       Impact factor: 4.310

2.  Binge ethanol intake in chronically exposed rat liver decreases LDL-receptor and increases angiotensinogen gene expression.

Authors:  Annayya R Aroor; Shivendra D Shukla
Journal:  World J Hepatol       Date:  2011-09-27

3.  MG132, a proteasome inhibitor, enhances LDL uptake in HepG2 cells in vitro by regulating LDLR and PCSK9 expression.

Authors:  Hong Yan; Yan-ling Ma; Yu-zhou Gui; Shu-mei Wang; Xin-bo Wang; Fei Gao; Yi-ping Wang
Journal:  Acta Pharmacol Sin       Date:  2014-07-21       Impact factor: 6.150

4.  Ascorbic acid enhances low-density lipoprotein receptor expression by suppressing proprotein convertase subtilisin/kexin 9 expression.

Authors:  Dandan Wang; Xiaoxiao Yang; Yuanli Chen; Ke Gong; Maoyun Yu; Yongyao Gao; Ximei Wu; Huaqing Hu; Chenzhong Liao; Jihong Han; Yajun Duan
Journal:  J Biol Chem       Date:  2020-09-10       Impact factor: 5.157

5.  Domain swapping reveals that low density lipoprotein (LDL) type A repeat order affects ligand binding to the LDL receptor.

Authors:  Taichi Yamamoto; Robert O Ryan
Journal:  J Biol Chem       Date:  2009-03-26       Impact factor: 5.157

6.  Protein kinase C activation stabilizes LDL receptor mRNA via the JNK pathway in HepG2 cells.

Authors:  Noelle B Vargas; Brandy Y Brewer; Terry B Rogers; Gerald M Wilson
Journal:  J Lipid Res       Date:  2008-10-20       Impact factor: 5.922

7.  Circulating soluble ICAM-1 levels shows linkage to ICAM gene cluster region on chromosome 19: the NHLBI Family Heart Study follow-up examination.

Authors:  Suzette J Bielinski; James S Pankow; Catherine Leiendecker Foster; Michael B Miller; Paul N Hopkins; John H Eckfeldt; Jim Hixson; Yongmei Liu; Tom Register; Richard H Myers; Donna K Arnett
Journal:  Atherosclerosis       Date:  2007-11-28       Impact factor: 5.162

8.  Cholesterol-lowering Action of BNA-based Antisense Oligonucleotides Targeting PCSK9 in Atherogenic Diet-induced Hypercholesterolemic Mice.

Authors:  Tsuyoshi Yamamoto; Mariko Harada-Shiba; Moeka Nakatani; Shunsuke Wada; Hidenori Yasuhara; Keisuke Narukawa; Kiyomi Sasaki; Masa-Aki Shibata; Hidetaka Torigoe; Tetsuji Yamaoka; Takeshi Imanishi; Satoshi Obika
Journal:  Mol Ther Nucleic Acids       Date:  2012-05-15       Impact factor: 10.183

9.  Monocytes of patients with familial hypercholesterolemia show alterations in cholesterol metabolism.

Authors:  Sandy Mosig; Knut Rennert; Petra Büttner; Siegfried Krause; Dieter Lütjohann; Muhidien Soufi; Regine Heller; Harald Funke
Journal:  BMC Med Genomics       Date:  2008-11-28       Impact factor: 3.063

10.  Cholesterol-dependent anaplasma phagocytophilum exploits the low-density lipoprotein uptake pathway.

Authors:  Qingming Xiong; Mingqun Lin; Yasuko Rikihisa
Journal:  PLoS Pathog       Date:  2009-03-13       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.